Covered recipient · General Payments record
STEPHEN W NESBIT
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2021–2024
$548.28
- Reported across 36 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $522.73 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $167.60 | 6 |
| ABBVIE INC. | $157.48 | 17 |
| PFIZER INC. | $49.93 | 3 |
| Lilly USA, LLC | $34.12 | 2 |
| Acerta Pharma LLC | $29.73 | 2 |
| Recor Medical Inc | $17.79 | 1 |
| Corcept Therapeutics | $17.65 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.18 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $17.00 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14.25 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2021
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $6.65 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105111490 | CMS |
| ABBVIE INC. | $7.52 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105111492 | CMS |
| ABBVIE INC. | $6.94 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105111494 | CMS |
| ABBVIE INC. | $20.94 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105111496 | CMS |
| ABBVIE INC. | $6.33 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105111498 | CMS |
| ABBVIE INC. | $5.09 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105111500 | CMS |
| ABBVIE INC. | $9.50 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105111502 | CMS |
| ABBVIE INC. | $17.25 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105111504 | CMS |
| ABBVIE INC. | $6.43 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105111506 | CMS |
| ABBVIE INC. | $8.63 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105111508 | CMS |
| ABBVIE INC. | $7.19 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105111510 | CMS |
| ABBVIE INC. | $17.76 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105111512 | CMS |
| ABBVIE INC. | $5.98 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105111514 | CMS |
| ABBVIE INC. | $2.58 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105111516 | CMS |
| ABBVIE INC. | $4.55 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105111518 | CMS |
| ABBVIE INC. | $9.28 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105111520 | CMS |
| ABBVIE INC. | $14.86 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105111522 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.40 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104368353 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.33 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105568329 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $17.00 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086173902 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14.25 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117976886 | CMS |
| Corcept Therapeutics | $17.65 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117740910 | CMS |
| Lilly USA, LLC | $14.83 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135350448 | CMS |
| Lilly USA, LLC | $19.29 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135350450 | CMS |
| Novo Nordisk Inc | $15.46 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096707521 | CMS |
| Novo Nordisk Inc | $13.85 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097411361 | CMS |
| Novo Nordisk Inc | $14.31 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097635285 | CMS |
| Novo Nordisk Inc | $18.54 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097239566 | CMS |
| Novo Nordisk Inc | $17.80 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097433358 | CMS |
| Novo Nordisk Inc | $87.64 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097166991 | CMS |
| PFIZER INC. | $18.86 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131569074 | CMS |
| PFIZER INC. | $13.98 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131514177 | CMS |
| PFIZER INC. | $17.09 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131490305 | CMS |
| Recor Medical Inc | $17.79 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127685740 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.18 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137642740 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2024
- Source files
- Dataset page · Bulk file · PY2021 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.